Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity

Journal: Journal of Clinical Investigation

Published: 2020-01-21

DOI: 10.1172/jci131126

Affiliations: 7

Authors: 27

Go to article
Institutions Share
NIH NIDDK Diabetes, Endocrinology, and Obesity Branch, United States of America (USA) 0.56
Cedars-Sinai Diabetes and Obesity Research, United States of America (USA) 0.11
NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), United States of America (USA) 0.11
NIH Positron Emission Tomography (PET), United States of America (USA) 0.11
NIH NIDDK Liver Diseases Branch, United States of America (USA) 0.07
NYU Langone Medical Center (NYULMC), United States of America (USA) 0.04

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER